Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

NCT01298700 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

806

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma
Ocular Hypertension

Interventions

DRUG: bimatoprost 0.01% ophthalmic solution
DRUG: bimatoprost 0.03% ophthalmic solution

Sponsor

Allergan